Monoclonal antibody M195-I-131

Drug Profile

Monoclonal antibody M195-I-131

Alternative Names: Anti-CD33 monoclonal antibody-I-131

Latest Information Update: 04 Jul 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; PDL BioPharma
  • Class Antineoplastics; Monoclonal antibodies; Radiopharmaceuticals
  • Mechanism of Action CD33 antigen inhibitors; Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Myeloid leukaemia

Most Recent Events

  • 04 Jul 2006 Discontinued - Clinical-Phase-Unknown for Myeloid leukaemia in USA (IV)
  • 31 Dec 2001 This agent is still in active development
  • 08 Sep 1998 Profile reviewed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top